| Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
|---|
| 02/06/2003 | US20030027826 Useful for treating atherosclerosis and other coronary artery disease;reacting an amine compound with an epoxide derivative in presence of transition metal salt catalyst |
| 02/06/2003 | US20030027822 Sodium channel modulators |
| 02/06/2003 | US20030026751 Stabilizing agent for hydroxylamine solutions |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1082121A4 Hiv integrase inhibitors |
| 02/05/2003 | CN1394855A Substituted heterocyclic compound |
| 02/04/2003 | US6515050 An extruding auxiliary using the above novel water-soluble polyurethane; additive for underwater concrete |
| 02/04/2003 | US6515028 Glucamine compounds for treating hepatitis virus infections |
| 02/04/2003 | US6514995 Metal complex is capable of forming a benzenoid diradical under physiological conditions and/or under photothermal conditions |
| 02/04/2003 | US6514934 For treating sexual dysfunctions in males and females |
| 01/30/2003 | WO2003008668A1 Corrosion inhibitors with improved water solubility and improved film persistence |
| 01/30/2003 | US20030023096 Useful as anti-hyperlipemia, for the prevention of abortion, for analgesics, as antidiarrheals, sleep inducer, diuretic, anti-diabetes, abortient, cathartics, antiulcer, anti-gastritis or antihypertensive etc. |
| 01/30/2003 | US20030022900 Compositions comprising alpha-1C specific compounds |
| 01/29/2003 | EP1278885A1 Resolution of aminotetralins |
| 01/29/2003 | EP1278716A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists |
| 01/28/2003 | US6511966 Administering for therapy of mitochondria medited disease |
| 01/28/2003 | CA2148839C Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
| 01/24/2003 | WO2002016308A1 Phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines |
| 01/23/2003 | WO2003006628A2 Nad synthetase inhibitors and uses thereof |
| 01/23/2003 | WO2003006452A1 New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 01/23/2003 | WO2003006420A1 Catalytic method to convert aryl compounds to aryl amines |
| 01/23/2003 | WO2003005965A2 Modulators of ceramidase and methods of use based thereon |
| 01/23/2003 | WO2001098245A3 Triphenyl compounds as interleukin-4 antagonists |
| 01/23/2003 | US20030018207 Pharmaceutical medication associated with insulin resistance; patient with prophylaxis conditions having reduced sensitivity to insulin |
| 01/23/2003 | US20030018083 Methods of treating and preventing pain, anxiety, and incontinence using derivatives of (-)-venlafaxine |
| 01/22/2003 | EP1031556B1 2-phenoxyaniline derivatives |
| 01/22/2003 | EP0968174B1 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock |
| 01/22/2003 | EP0721935B1 Organic electroluminescent element and arylenediamine derivative |
| 01/21/2003 | US6509472 For use in enantioselective reduction of prochiral ketones to chiral secondary alcohols |
| 01/21/2003 | US6509356 1-(4-(Substituted alkoxy)benzyl)naphthalene compounds having estrogen inhibitory activity |
| 01/21/2003 | US6509309 Cleaning composition comprising alkoxy substituted perfluoro compounds |
| 01/16/2003 | WO2002045658A3 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
| 01/16/2003 | WO2002034247A3 Anticancer agents based on regulation of protein prenylation |
| 01/16/2003 | WO2001062705A3 Aminoalcohol derivatives |
| 01/16/2003 | US20030013713 Compounds as PDE IV and TNF-inhibitors |
| 01/15/2003 | EP1275635A1 Calcium receptor-active compounds |
| 01/15/2003 | EP0912572B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
| 01/15/2003 | CN1098844C Substituted biphenyloxazolines |
| 01/15/2003 | CN1098841C Novel amide derivatives and medicinal compositions thereof |
| 01/14/2003 | US6506941 Venlafaxine production process |
| 01/14/2003 | CA2064919C Adducts of epoxides and amines |
| 01/09/2003 | WO2003002525A1 NOVEL N-BISARYL- AND N-ARYL-CYCLOALKYLIDENYL-$G(a)-SULFIN- AND $G(a)-SULFONAMINO ACID AMIDES |
| 01/09/2003 | WO2002018325A3 Process for the preparation of substituted phenylacetonitriles |
| 01/09/2003 | US20030008907 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof |
| 01/09/2003 | US20030008876 Can mimic or block the effect of extracellular calcium on a cell surface calcium receptor; for use in therapy |
| 01/09/2003 | US20030008768 Catalyst for aromatic C-O, C-N, and C-C bond formation |
| 01/09/2003 | CA2450708A1 Novel n-bisaryl- and n-aryl-cycloalkylidenyl .alpha.-sulfin- and .alpha.-sulfonamino acid amides |
| 01/08/2003 | EP1272537A2 Ether-amine based polymerization catalysts, compositions and processes using same |
| 01/08/2003 | EP0978506B1 2-phenoxyaniline derivatives |
| 01/08/2003 | EP0975579B1 Living olefin polymerization processes |
| 01/08/2003 | CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 01/08/2003 | CN1390122A Tissue factor antagonists and methods of use thereof |
| 01/08/2003 | CN1098278C Cinnamic acid derivative |
| 01/07/2003 | US6504059 Catalytic reductive hydroxylation of 2,5-dichloronitrobenzene, in the presence of acids, water miscible and insoluble solvent or cosolvents to form 2,5-dichloro-4-aminophenol |
| 01/07/2003 | US6503942 (4-(2-(Dimethylamino)-1-(1- hydroxy cyclohexyl)ethyl)phenoxy) methyl pivalate, for example; treating central nervous system disorders including post-traumatic stress, depression, anxiety disorder, autism, cocaine and alcohol addiction |
| 01/03/2003 | WO2003000645A1 Method for producing aminostilbene derivative |
| 01/02/2003 | US20030004360 Processes and intermediates for preparing benzyl epoxides |
| 01/02/2003 | EP1270546A1 Process for producing 1,3-bis(3-aminophenoxy)benzene |
| 01/02/2003 | EP1270545A1 Process for producing amine derivatives |
| 01/02/2003 | EP1268396A1 Diphenyl ether compounds useful in therapy |
| 01/02/2003 | EP1268366A2 Modifying chemoselectivity during oxidation of nitrogen compounds |
| 01/02/2003 | EP1268050A2 Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form |
| 01/01/2003 | CN1388800A Novel styryl componds and organic electroluminescent devices |
| 01/01/2003 | CN1388149A Diamino benzene derivant, polyimide using the same derivant and liquid crystal oriented film |
| 12/31/2002 | US6500213 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives |
| 12/27/2002 | WO2002102875A2 Polymers comprising cf2o structural elements |
| 12/26/2002 | US20020198399 Useful as intermediates or raw materials for the synthesis of agricultural chemicals, pharmaceuticals |
| 12/26/2002 | US20020198251 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/24/2002 | US6498191 For treatment of alzheimer's disease, diabetes mellitus, parkinson's disease, neuronal and cardiac ischemia, huntington's disease, stroke |
| 12/24/2002 | CA2150812C Catechol diethers as selective pde iv inhibitors |
| 12/19/2002 | WO2002100813A2 Modulators of peroxisome proliferator activated receptors |
| 12/19/2002 | WO2002100364A1 Novel coupler components for oxidative hair colouring |
| 12/19/2002 | WO2002100341A2 Compounds for the treatment of metabolic disorders |
| 12/19/2002 | WO2002042248A3 Naphthalene derivatives |
| 12/19/2002 | US20020193636 Benzaldehyde reacted with a primary amine to give an imine, which is hydrogenated with hydrogen in the presence of a catalyst and a water miscible solvent |
| 12/19/2002 | US20020193447 Chemical intermediates for bronchodilators |
| 12/19/2002 | US20020193347 Using an optically active N-substituted chiral derivative of norephedrine as ligand for enantioselective reduction of unsaturated compounds carrying functional groups by a hydrogen transfer method |
| 12/19/2002 | US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 12/19/2002 | DE10128472A1 Oxidative dyeing compositions for keratin fibers contain m-phenylenediamine derivatives (some of which are novel compounds) as couplers giving red shades with conventional developers |
| 12/19/2002 | CA2449256A1 Modulators of peroxisome proliferator activated receptors |
| 12/18/2002 | EP1265839A1 Compounds active at the glucocorticoid receptor |
| 12/18/2002 | EP1265483A2 Use of phenylethylamine derivatives for the anitmicrobial treatment of surfaces |
| 12/17/2002 | US6495607 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 12/17/2002 | US6495546 Propanolamine derivatives |
| 12/12/2002 | WO2002098400A1 Novel arylaminopropane analogues and their use for the treatment of glaucoma |
| 12/12/2002 | WO2002066415A3 Non-steroidal modulators of estrogen receptors |
| 12/12/2002 | CA2447479A1 Novel arylaminopropane analogues and their use for the treatment of glaucoma |
| 12/11/2002 | EP1263763A2 Tubulin binding ligands and corresponding prodrug constructs |
| 12/11/2002 | EP1263715A1 Novel phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263714A1 Novel phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263711A1 Novel use of phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1100805B1 Medicine nitrate salts |
| 12/11/2002 | EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 12/11/2002 | EP0624155B2 Carbamates and plant-protecting agents containing them |
| 12/11/2002 | CN1384814A Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 12/11/2002 | CN1384740A Delayed-action form of administration containing tramadol saccharinate |
| 12/11/2002 | CN1384735A Oral dosage forms |
| 12/10/2002 | US6492559 Alkylated aminoether surfactants |
| 12/10/2002 | US6492557 A bis(aminostyryl)naphthalene compound represented by the formula (6) below. the compound of the present invention emits intense yellow to red light depending on the substituent groups introduced therein. therefore, it is organic light |